BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12853388)

  • 21. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis.
    Magnarelli LA; Lawrenz M; Norris SJ; Fikrig E
    J Med Microbiol; 2002 Aug; 51(8):649-655. PubMed ID: 12171295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization and expression of p23 (OspC) from a North American strain of Borrelia burgdorferi.
    Padula SJ; Sampieri A; Dias F; Szczepanski A; Ryan RW
    Infect Immun; 1993 Dec; 61(12):5097-105. PubMed ID: 8225587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
    Magnarelli LA; Fikrig E; Padula SJ; Anderson JF; Flavell RA
    J Clin Microbiol; 1996 Feb; 34(2):237-40. PubMed ID: 8788993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
    Callister SM; Schell RF; Case KL; Lovrich SD; Day SP
    J Infect Dis; 1993 Jan; 167(1):158-64. PubMed ID: 8418162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
    Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
    Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.
    Hauser U; Krahl H; Peters H; Fingerle V; Wilske B
    J Clin Microbiol; 1998 Feb; 36(2):427-36. PubMed ID: 9466753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.
    Magnarelli LA; Ijdo JW; Padula SJ; Flavell RA; Fikrig E
    J Clin Microbiol; 2000 May; 38(5):1735-9. PubMed ID: 10790090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.
    Arnaboldi PM; Seedarnee R; Sambir M; Callister SM; Imparato JA; Dattwyler RJ
    Clin Vaccine Immunol; 2013 Apr; 20(4):474-81. PubMed ID: 23365204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
    Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
    J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody.
    Remington MC; Munson EL; Callister SM; Molitor ML; Christopherson JA; DeCoster DJ; Lovrich SD; Schell RF
    Infect Immun; 2001 Jul; 69(7):4268-75. PubMed ID: 11401963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.
    Zajkowska J; Lelental N; Kulakowska A; Mroczko B; Pancewicz S; Bucki R; Kornhuber J; Lewczuk P
    Immunol Lett; 2015 Nov; 168(1):58-63. PubMed ID: 26210581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.